Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-07-03 Sale |
2023-07-03 7:43 pm |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
16,356 | $8.8495 | $144,743 | 321,467 (Indirect Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 7:12 pm |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
20,443 | $6.0856 | $124,407 | 337,823 (Indirect Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 8:07 pm |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
4,871 | $10.33 | $50,338 | 292,846 (Indirect Direct) |
View |
| 2022-12-15 Sale |
2022-12-16 6:36 pm |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
19,648 | $11.14 | $218,963 | 296,050 (Indirect Direct) |
View |
| 2022-07-29 Sale |
2022-08-02 9:42 pm |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
10,375 | $6.6668 | $69,168 | 315,698 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-07-03 Exercise |
2023-07-03 7:43 pm |
N/A 2031-01-28 |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
16,356 | $0 | 321,467 (Direct) |
View |
| 2023-07-03 Exercise |
2023-07-03 7:43 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
16,356 | $1.04 | 321,467 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 7:12 pm |
N/A 2031-01-28 |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
20,443 | $0 | 337,823 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 7:12 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
20,443 | $1.04 | 337,823 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 7:08 pm |
N/A 2033-02-14 |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-05-31 Ownership |
2023-02-14 5:15 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
1,667 | $5.77 | 297,717 (Direct) |
View |
Ownership |
2023-02-14 5:15 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
0 | $0 | 297,717 (Indirect) |
View |
| 2022-11-10 Option Award |
2022-11-14 6:58 pm |
N/A 2032-11-09 |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
82,580 | $0 | 82,580 (Direct) |
View |
| 2022-02-18 Gift |
2022-08-02 9:42 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
20,000 | $0 | 315,698 (Indirect) |
View |
| 2022-02-10 Option Award |
2022-02-14 7:04 pm |
N/A 2032-02-09 |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
101,435 | $0 | 428,023 (Direct) |
View |
| 2021-12-31 Gift |
2022-02-14 7:04 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
10,000 | $0 | 428,023 (Indirect) |
View |
| 2021-08-02 Conversion |
2021-08-02 9:26 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
270,365 | $0 | 334,922 (Indirect) |
View |
| 2021-07-30 Option Award |
2021-08-02 9:26 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
41,500 | $15 | 334,922 (Direct) |
View |
Ownership |
2021-07-28 9:22 pm |
N/A N/A |
Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer |
0 | $0 | 651,785 (Direct) |
View |